Douglas E. Williams, Director at ANADYS PHARMACEUTICALS INC (ANDS), bought 2,000 shares at $2.36 ($5K) on 2007-09-04, disclosed to the SEC on 2007-09-05.
Open-market purchase of $5k ANDS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| CDAK | SELL | 2023-01-23 | $3K | — | Filing → |
| OVID | BUY | 2018-08-16 | $32K | — | Filing → |
| BIIB | SELL | 2015-06-22 | $1.6M | — | Filing → |